| Literature DB >> 32224059 |
Isadora Zago Miotto1, Vanessa Rolim Bessa2, Luana Barreto de Almeida Vasconcelos2, Luciana Paula Samorano2, Maria Cecília Rivitti-Machado2, Zilda Najjar Prado de Oliveira2.
Abstract
OBJECTIVE: The aim of this study was to identify the pattern of pediatric dermatoses of patients evaluated at a dermatologic clinic of a reference center in Brazil and to compare these results to similar surveys conducted in other countries.Entities:
Keywords: Atopic dermatitis; Epidemiology; Genodermatoses; Pediatric dermatology
Mesh:
Year: 2020 PMID: 32224059 PMCID: PMC9432250 DOI: 10.1016/j.jped.2020.02.002
Source DB: PubMed Journal: J Pediatr (Rio J) ISSN: 0021-7557 Impact factor: 2.990
Prevalence of skin diseases by groups (n = 2668).
| Groups of diseases | Frequency ( | Frequency (%) |
|---|---|---|
| - Atopic dermatitis | 489 | 58.8 |
| - Psoriasis | 91 | 10.9 |
| - Lichen planus | 31 | 3.7 |
| - Contact dermatitis | 25 | 3.0 |
| - Others | 196 | 23.6 |
| - Keratinization disorders | 75 | 19.8 |
| - Epidermolysis bullosa | 68 | 17.9 |
| - Neurofibromatosis/Legius | 56 | 14.8 |
| - Cutaneous mosaicism | 47 | 12.4 |
| - Others | 133 | 35.1 |
| - Viral infections | 163 | 48.7 |
| - Fungal infections | 82 | 24.5 |
| - Ectoparasitosis | 44 | 13.1 |
| - Bacterial infections | 42 | 12.5 |
| - Protozoal infections | 4 | 1.2 |
| - Acne vulgaris | 133 | 39.8 |
| - Alopecia areata | 54 | 16.2 |
| - Onychocryptosis | 30 | 9.0 |
| - Hyperhidrosis | 11 | 3.3 |
| - Others | 106 | 31.7 |
| - Melanocytic nevi | 108 | 37.9 |
| - Epidermal nevi | 43 | 15.1 |
| - Proliferation and tumors of connective/muscular/neural/adipose tissues | 31 | 10.9 |
| - Mastocytosis | 27 | 9.5 |
| - Others | 76 | 26.7 |
| - Infantile hemangioma | 105 | 56.1 |
| - Vascular malformations | 44 | 23.5 |
| - Pyogenic granuloma | 16 | 8.6 |
| - Syndrome-related vascular malformations | 12 | 6.4 |
| - Others | 10 | 5.3 |
| - Scleroderma | 65 | 71.4 |
| - Lupus erythematosus | 15 | 16.5 |
| - Dermatomyositis | 9 | 9.9 |
| - Others | 2 | 2.2 |
| - Vitiligo | 81 | 94.2 |
| - Postinflammatory dyschromia | 2 | 2.3 |
| - Melasma | 3 | 3.5 |
| - Figurate purpura | 7 | 31.8 |
| - Leukocytoclastic vasculitis | 5 | 22.7 |
| - Henoch-Schonlein purpura | 2 | 9.1 |
| - Behcet disease | 2 | 9.1 |
| - Others | 6 | 27.3 |
| - Fixed drug eruption | 9 | 42.9 |
| - Erythema multiforme | 5 | 23.8 |
| - Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum | 4 | 19.0 |
| - DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) | 1 | 4.8 |
| - Others | 2 | 9.5 |
| - Linear IgA bullous dermatosis | 6 | 37.5 |
| - Pemphigus foliaceus | 3 | 18.7 |
| - Pemphigus vulgaris | 3 | 18.7 |
| - Bullous pemphigoid | 2 | 12.6 |
| - Others | 2 | 12.6 |
| - Others | 23 | 100 |
| - Under investigation | 56 | 100 |
The frequencies in italic are related to the prevalence of skin diseases by groups and the frequencies not in italic correspond to the frequency in each group.
Included eczematous dermatitis, seborrheic dermatitis, pityriasis rosea, urticaria, granuloma annulare, pityriasis lichenoides chronica, pityriasis lichenoides et varioliformis acuta, strophulus, lichen striatus, lichen nitidus, pityriasis alba, graft-vs.-host disease, and panniculitis.
Included ectodermal dysplasia, tuberous sclerosis, genodermatoses with acromia, genodermatoses with high potential for developing neoplasms, and primary immunodeficiencies.
Included hidradenitis suppurativa, acneiform eruptions, perioral dermatitis, folliculitis decalvans, folliculitis scalp, acne keloidalis nuchae, rosacea, keratosis pilaris, androgenetic alopecia, congenital alopecia, traction alopecia, telogen effluvium, subungual exostosis, melanonychia striata, paronychia, miliaria, hematidrosis, and bromhidrosis.
Included development anomalies, cysts, histiocytosis, leukemia and lymphomas, and benign epidermal neoplasms.
Included congenital hemangioma, neoplasms, and undefined vascular malformations.
Included connective tissue overlap syndromes.
Included livedoid vasculopathy, vitamin C deficiency-related purpura, and purpura simplex.
Included morbilliform drug reaction and fixed drug eruption.
Included dermatitis herpetiformis and pemphigus herpetiformis.
Included acanthosis nigricans, calcinosis cutis, dermatitis artefacta, stretch marks, follicular mucinosis, and porphyria cutanea tarda.
Prevalence and causes of pediatric hospitalization in the study period (n = 56).
| Causes of pediatric hospitalization | Frequency ( | Frequency (%) |
|---|---|---|
| - Atopic dermatitis | 20 | 80.0 |
| - Psoriasis | 2 | 8.0 |
| - Drug reaction | 2 | 8.0 |
| - Infected eczema | 1 | 4.0 |
| - Congenital melanocytic nevus | 2 | 11.1 |
| - Tuberous sclerosis | 2 | 11.1 |
| - Neurofibromatosis | 2 | 11.1 |
| - Other | 12 | 66.7 |
| - PHACES syndrome | 3 | 42.8 |
| - LUMBAR syndrome | 1 | 14.3 |
| - Infantile hemangioma | 2 | 28.6 |
| - Vascular malformation | 1 | 14.3 |
| - Psoriasis | 1 | 16.7 |
| - Erythroderma | 1 | 16.7 |
| - Metastatic calcinosis | 1 | 16.7 |
| - Other | 3 | 50.0 |
The frequencies in italic are related to the groups of causes of pediatric hospitalization and the frequencies not in italic correspond to the frequency in each group.
Included angiokeratoma, scleroderma, warts, ungual lichen planus, Rothmund–Thomson syndrome, ungual melanoma, molluscum contagiosum, epidermal cysts, onychocryptosis, nevus verrucosus, and pilomatricoma.
PHACES syndrome: posterior fossa brain malformations, hemangioma, arterial lesions, cardiac abnormalities, eye abnormalities, and malformations of the sternal cleft, supraumbilical raphe, or both.
LUMBAR syndrome: lower body hemangioma and other cutaneous defects, urogenital anomalies, myelopathy, bone deformities, anorectal malformations, arterial anomalies, renal anomalies.
Included dermatomyositis, reflex sympathetic dystrophy, and panniculitis.
Complementary diagnostic exams by disease group.
| Disease group | Biopsy ( | DME ( | IMM ( | DIF ( | IIF ( | MDMP ( | WL ( |
|---|---|---|---|---|---|---|---|
| Total ( | |||||||
| Inflammatory diseases | 190/21.5 | 268/38.7 | 1/1.6 | 25/22.1 | 3/18.7 | 63/41.4 | 26/14.4 |
| Genodermatoses | 191/21.6 | 86/12.4 | 59/95.2 | 24/21.2 | 3/18.7 | 5/3.3 | 31/17.2 |
| Infectious diseases | 81/9.2 | 119/17.2% | – | 6/5.3 | 2/12.5 | 45/29.6 | 30/16.7 |
| Adnexal disorders | 62/7.0 | 73/10.5 | – | – | – | 14/9.2 | 9/5.0 |
| Cysts and neoplasms | 147/16.6 | 36/5.2 | – | 2/1.8 | – | 5/3.3 | 9/5.0 |
| Vascular disorders | 42/4.7 | 21/3.0 | – | 1/0.9 | – | 2/1.3 | 1/0.5 |
| Connective tissue disorders | 67/7.6 | 19/2.7 | 1/1.6 | 21/18.6 | – | 1/0.6 | 11/6.1 |
| Pigmentary disorders | 18/2.0 | 31/4.5 | – | 3/2.7 | – | 3/2.0 | 54/30.0 |
| Purpura and vasculitis | 17/1.9 | 5/0.7 | – | 8/7.1 | – | – | 1/0.5 |
| Drug reactions | 14/1.6 | 6/0.9 | – | 2/1.8 | – | 2/1.3 | – |
| Autoimmune bullous diseases | 13/1.5 | 3/0.4 | – | 12/10.6 | 8/50.0 | 2/1.3 | – |
| Others | 12/1.4 | 6/0.9 | – | 1/0.9 | – | 3/2.0 | 1/0.5 |
| Under investigation | 31/3.5 | 20/2.9 | 1/1.6 | 8/7.1 | – | 7/4.6 | 7/3.9 |
Percentages were calculated according to the number of exams performed by group of disease.
DME, direct mycological examination; IMM, immunological mapping; DIF, direct immunofluorescence; IIF, indirect immunofluorescence; MDMP, microscopy detection of parasites; WL, Wood's light.
Literature review: comparison with similar studies.
| Study | Institution Country | Study duration (months) | Period of study | Subjects ( | Most frequent skin diseases |
|---|---|---|---|---|---|
| Vakirlis et al. | First Department of Dermatology of the Aristotle University Medical School, Thessaloniki, Greece | 36 | January 2013 to December 2015 | 940 | Dermatitis/eczema (31.5%) |
| Sacchidanand et al. | Department of Dermatology, STD and Leprosy, Victoria Hospital, South India | 4 | January 2011 to June 2011 | 1090 | Infections/infestations (32.4%) |
| Nanda et al. | Pediatric Dermatology Clinic, Asad’ Al-Hammad Dermatology Center, Kuwait | 48 | July 1992 to June 1996 | 10,000 | Atopic dermatitis (31.3%) |
| Wenk et al. | Department of Dermatology at the Kantonsspital Aarau, Switzerland | 39 | 1998 to 2001 | 1105 | Atopic dermatitis (25.9%) |
| Hon et al. | Pediatric Dermatology Clinic at the Prince of Wales Hospital (PWH), Hong Kong, China | 12 | January 2000 to December 2000 | 331 | Eczema (33%) |
| Tamer et al. | First Dermatology Clinic, Ankara, Turkey | 36 | 2004 to 2006 | 6300 | Acne vulgaris (12.4%) |
| Pozzo-Magaña et al. | Dermatology Service of the Instituto Nacional de Pediatría, Mexico City, Mexico | 120 | January 1994 to December 2003 | 5250 | Atopic dermatitis (14.6%) |
| Kelbore et al. | Wolaita Sodo Teaching and Referral Hospital, Ethiopia | 24 | January 2016 to December 2017 | 1704 | Impetigo (13.8%) |
| Ayanlowo et al. | Lagos University Teaching Hospital, Nigeria | 156 | January 2004 to December 2016 | 6373 | Atopic dermatitis (15.1%) |
| Present study | Dermatology Division of the Hospital das Clínicas, University of São Paulo Medical School, Brazil | 12 | January 2017 to December 2017 | 2330 | Atopic dermatitis (18.3%) |